Literature DB >> 10344366

Familial relapsing haemolytic uraemic syndrome and complement factor H deficiency.

P Warwicker1, R L Donne, J A Goodship, T H Goodship, A J Howie, D S Kumararatne, R A Thompson, C M Taylor.   

Abstract

BACKGROUND: In a recent study of three families we have found that inherited haemolytic uraemic syndrome (HUS) maps to a region of chromosome 1q containing the gene for complement factor H. In one of these families and also in a case of sporadic D-HUS, we have identified mutations in the factor H gene. A further family with inherited HUS has therefore been investigated.
METHODS: DNA extracted from the family members and DNA extracted from archival post-mortem material from a deceased family member, was studied. Review of renal biopsies and study of complement components was also undertaken.
RESULTS: This family demonstrates an inherited deficiency of complement factor H. Non-diarrhoeal HUS has affected at least two family members with half normal levels of factor H.
CONCLUSION: These findings represent further evidence of the association between factor H dysfunction and HUS.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10344366     DOI: 10.1093/ndt/14.5.1229

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  11 in total

Review 1.  Renal transplantation in HUS patients with disorders of complement regulation.

Authors:  Lothar Bernd Zimmerhackl; Johanna Scheiring; Friederike Prüfer; C Mark Taylor; Chantal Loirat
Journal:  Pediatr Nephrol       Date:  2006-10-21       Impact factor: 3.714

Review 2.  The role of von Willebrand factor in thrombotic microangiopathy.

Authors:  Damien G Noone; Magdalena Riedl; Christoph Licht
Journal:  Pediatr Nephrol       Date:  2017-07-26       Impact factor: 3.714

3.  Atypical hemolytic uremic syndrome in the Tunisian population.

Authors:  Nadia Leban; Sabra Aloui; Dalel Touati; Ramzy Lakhdhar; Habib Skhiri; Gerard Lefranc; Abdellatif Achour; Mezri Elmay; Margarita Lopez-Trascasa; Pilar Sanchez-Corral; Jemni Chibani; Amel Haj Khelil
Journal:  Int Urol Nephrol       Date:  2010-05-25       Impact factor: 2.370

4.  Successful (?) therapy of hemolytic-uremic syndrome with factor H abnormality.

Authors:  Angela Gerber; Antje H Kirchhoff-Moradpour; Silke Obieglo; Matthias Brandis; Michael Kirschfink; Peter F Zipfel; Judith A Goodship; Lothar B Zimmerhackl
Journal:  Pediatr Nephrol       Date:  2003-06-26       Impact factor: 3.714

5.  Idiopathic Atypical Hemolytic Uremic Syndrome (aHUS) with Trilineage Myelodysplasia.

Authors:  Sudha Sethy; S R Mahapatra; R K Jena; P Bhunya; S Mahapatra
Journal:  Indian J Hematol Blood Transfus       Date:  2011-07-12       Impact factor: 0.900

6.  Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome.

Authors:  Tamara Manuelian; Jens Hellwage; Seppo Meri; Jessica Caprioli; Marina Noris; Stefan Heinen; Mihaly Jozsi; Hartmut P H Neumann; Giuseppe Remuzzi; Peter F Zipfel
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

Review 7.  The risk of recurrence of hemolytic uremic syndrome after renal transplantation in children.

Authors:  Chantal Loirat; Patrick Niaudet
Journal:  Pediatr Nephrol       Date:  2003-09-17       Impact factor: 3.714

8.  Successful split liver-kidney transplant for factor H associated hemolytic uremic syndrome.

Authors:  Jeffrey M Saland; Benjamin L Shneider; Jonathan S Bromberg; Patricia A Shi; Stephen C Ward; Margret S Magid; Corinne Benchimol; Mouin G Seikaly; Sukru H Emre; Elena Bresin; Giuseppe Remuzzi
Journal:  Clin J Am Soc Nephrol       Date:  2008-11-12       Impact factor: 8.237

9.  Clinico-pathological findings in diarrhoea-negative haemolytic uraemic syndrome.

Authors:  C M Taylor; C Chua; A J Howie; R A Risdon
Journal:  Pediatr Nephrol       Date:  2004-02-24       Impact factor: 3.714

Review 10.  Complement factor H in host defense and immune evasion.

Authors:  Raffaella Parente; Simon J Clark; Antonio Inforzato; Anthony J Day
Journal:  Cell Mol Life Sci       Date:  2016-12-10       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.